Qiuwei Pan to Hepatitis E
This is a "connection" page, showing publications Qiuwei Pan has written about Hepatitis E.
Connection Strength
4.776
-
No Clear Evidence for an Effect of Sofosbuvir Against Hepatitis E Virus in Organ Transplant Patients. Hepatology. 2019 04; 69(4):1846-1847.
Score: 0.549
-
The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response. Hepatology. 2018 06; 67(6):2096-2112.
Score: 0.516
-
Immunity against hepatitis E virus infection: Implications for therapy and vaccine development. Rev Med Virol. 2018 Mar; 28(2).
Score: 0.504
-
Genotype-specific acquisition, evolution and adaptation of characteristic mutations in hepatitis E virus. Virulence. 2018 01 01; 9(1):121-132.
Score: 0.492
-
RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production. Hepatology. 2017 06; 65(6):1823-1839.
Score: 0.482
-
Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections. Sci Signal. 2017 Apr 25; 10(476).
Score: 0.482
-
Hepatitis E Virus Infects Neurons and Brains. J Infect Dis. 2017 04 15; 215(8):1197-1206.
Score: 0.481
-
Distinct Antiviral Potency of Sofosbuvir Against Hepatitis CÂ and E Viruses. Gastroenterology. 2016 12; 151(6):1251-1253.
Score: 0.466
-
Chronic hepatitis E in an immunocompetent patient. Clin Res Hepatol Gastroenterol. 2020 06; 44(3):e66-e68.
Score: 0.142
-
RDW, NLR and RLR in predicting liver failure and prognosis in patients with hepatitis E virus infection. Clin Biochem. 2019 Jan; 63:24-31.
Score: 0.134
-
Hepatitis E virus infection in HIV-infected patients: A large cohort study in Yunnan province, China. J Med Virol. 2018 06; 90(6):1121-1127.
Score: 0.128
-
Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient. Gastroenterology. 2018 03; 154(4):1199-1201.
Score: 0.127
-
Direct-acting antiviral therapy for hepatitis E virus? Lancet Gastroenterol Hepatol. 2017 03; 2(3):154-155.
Score: 0.119
-
Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replication. Antiviral Res. 2017 04; 140:1-12.
Score: 0.118
-
The Interplay between Host Innate Immunity and Hepatitis E Virus. Viruses. 2019 06 11; 11(6).
Score: 0.035